Tilray Brands (TLRY) Liabilities and Shareholders Equity (2017 - 2026)

Tilray Brands (TLRY) reported Liabilities and Shareholders Equity of $2.1 billion for Q1 2026, down 1.14% quarter-over-quarter from $2.1 billion in Q4 2025.

Tilray Brands (TLRY) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Tilray Brands has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $2.1 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $2.1 billion; the trailing twelve-month figure through Feb 2026 stood at $8.3 billion (down 34.28% YoY), and the FY2025 full-year result was $2.1 billion, down 50.86% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $2.1 billion, down from $2.1 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $5.8 billion in Q1 2022, with the low at $2.1 billion in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $4.1 billion across 5 years, with a median of $4.3 billion in 2023.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity declined 1.99% — and 2025, when it slumped 51.13%.
  • Tilray Brands' Liabilities and Shareholders Equity stood at $5.5 billion in 2022, then retreated by 20.89% to $4.3 billion in 2023, then dropped by 3.21% to $4.2 billion in 2024, then plunged by 49.94% to $2.1 billion in 2025, then decreased by 1.14% to $2.1 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 40.04 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.26 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.35 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 2.27 Bn
10 Tilray Brands - - 54.95 Mn 2.07 Bn

Historic Data

Download Data
DateValue
Feb 28, 2026 2.07 Bn
Nov 30, 2025 2.10 Bn
Aug 31, 2025 2.08 Bn
May 31, 2025 2.07 Bn
Nov 30, 2024 4.19 Bn
Aug 31, 2024 4.26 Bn
May 31, 2024 4.22 Bn
Feb 29, 2024 4.21 Bn
Nov 30, 2023 4.33 Bn
Aug 31, 2023 4.40 Bn
May 31, 2023 4.31 Bn
Feb 28, 2023 4.38 Bn
Nov 30, 2022 5.47 Bn
Aug 31, 2022 5.59 Bn
May 31, 2022 5.45 Bn
Feb 28, 2022 5.82 Bn
Nov 30, 2021 5.76 Bn
Aug 31, 2021 5.99 Bn
May 31, 2021 6.03 Bn
May 31, 2020 1.74 Bn